SFA
TNYA icon

Sequoia Financial Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Sequoia Financial Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.93K Hold
10,725
– – ﹤0.01% 2159
2026
Q1 		$7.43K Hold
10,725
– – ﹤0.01% 1915
2025
Q4 		$7.63K Buy
+10,725
New +$14.6K ﹤0.01% 1921

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sequoia Financial Advisors's TNYA Position: Q2 2026 in Review

Sequoia Financial Advisors held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 10,725 shares worth $7.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Sequoia Financial Advisors first reported a position in TNYA in Q4 2025 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Sequoia Financial Advisors held 10,725 shares of Tenaya Therapeutics worth $7.93K as of Q2 2026.
  • Sequoia Financial Advisors left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2159 holding.
  • Sequoia Financial Advisors first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.